Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Sitagliptin for Inpatient Type 2 Diabetes
NCT02250794Phase 4Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Oct 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs), sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Rush University Medical Center. Planned start Oct 2014; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02250794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250794.